Beyond Biotech - the podcast from Labiotech

The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie


Listen Later

Biotechnology has always been a dynamic domain, but the world of finance that provides the fuel for the fire is just as vibrant. Trying to predict where the market for biotech investment is heading is always risky but for experts like Baker McKenzie’s Roel Meers, understanding where the market is moving is where he eats.

I spoke to Roel this week to unpack just where biotech funding stands in Q2 2025, to get a feel for the sorts of M&As, IPOs, and licensing deals we should be looking for in the second half of the year. We also talk about some alternative financing options for innovators and early-stage firms.

01:09                      Introducing Roel Meers

02:18                     Corporate finance and the life sciences

04:53                      Brussels, Europe, and beyond: Baker McKenzie’s global footprint

06:21                      Navigating life science regulations and regulators

10:33                      De-risking biotech investments in uncertain times

11:57                      How investors are minimizing risk in 2025

13:35                      Funding trends for biotechs in emerging hubs, including Benelux

15:58                      The deal types that will dominate 2025

17:35                      The therapeutic areas where deals are being done

19:16                      Trends in biotech in Europe, in North America, and in the Asia-Pacific

20:36                      Macroeconomics and biotechnology finance

22:54                      De-risking deals by lowering upfronts, increasing milestones

26:38                      What to consider when choosing alternative financing options

30:35                      When should biotechs bring in outside finance experts

33:47                      Looking beyond 2025 – what’s coming, and why

36:38                      How European biotechs can position themselves for funding success

Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! 

Stay updated by subscribing to our newsletter

To dive deeper into the topic: 

  • 2025 biotech funding tracker: recent highlights
  • The ABC of biotech startup funding
  • Top biotech grants and campaigns
...more
View all episodesView all episodes
Download on the App Store

Beyond Biotech - the podcast from LabiotechBy Labiotech

  • 3.3
  • 3.3
  • 3.3
  • 3.3
  • 3.3

3.3

3 ratings


More shows like Beyond Biotech - the podcast from Labiotech

View all
Fareed Zakaria GPS by CNN

Fareed Zakaria GPS

3,443 Listeners

Making Sense with Sam Harris by Sam Harris

Making Sense with Sam Harris

26,420 Listeners

The Bio Report by Levine Media Group

The Bio Report

39 Listeners

The Daily by The New York Times

The Daily

111,441 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

The Readout Loud by STAT

The Readout Loud

317 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

59 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

87 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

29 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

147 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

15,216 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

10 Listeners

The Foreign Affairs Interview by Foreign Affairs Magazine

The Foreign Affairs Interview

412 Listeners

Ground Truths by Eric Topol

Ground Truths

47 Listeners

The Wirecutter Show by The New York Times

The Wirecutter Show

1,071 Listeners